mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
7e-05 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-05 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-05 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
0.0002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0003 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0003 |